Turning the Tide on Venous Thromboembolism Applying Anticoagulation Best Practices to Reduce the Disease Burden
Activity Description and Educational Objectives
In this activity, an expert in cardiovascular medicine discusses several best practices for reducing the disease burden of venous thromboembolism (VTE).
Upon completion of this activity, participants will be able to:
- Implement evidence-based guidelines for initial and long-term anticoagulation in the treatment and secondary prevention of VTE
- Select direct oral anticoagulants (DOACs) for initial and long-term VTE management based on patient preferences, appropriate dosing regimens, and specific factors such as bleeding risk and comorbidity
- Outline best practices to improve VTE risk assessment and transitions of care for patients with VTE
- Educate and counsel patients on the use of DOACs, including comparative safety and efficacy data and the importance of adhering to DOAC therapy for secondary prevention of VTE
This activity has been designed to meet the educational needs of specialists in vascular medicine, pulmonology, vascular surgery, and hematology, as well as primary care providers, emergency medicine physicians, pharmacists, advanced practice clinicians, and other healthcare professionals involved in the treatment of patients with venous thromboembolism.
Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 80% or higher is needed to obtain CME/MOC credit and 70% or higher to obtain CNE/CPE credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/MOC/CNE/CPE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
February 01, 2019
January 31, 2020
Time to Complete
Faculty and Disclosure/Conflict of Interest Policy
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/CPE activity for any amount during the past 12 months.
Gregory Piazza, MD, MS
Assistant Professor of Medicine
Harvard Medical School
Staff Physician, Cardiovascular Division
Brigham and Women's Hospital
Gregory Piazza, MD, MS, has a financial interest/relationship or affiliation in the form of:
Consultant for Pfizer Inc.
Grant/Research Support from Bayer Corporation; Bristol-Myers Squibb; BTG/EKOS; Daiichi-Sankyo Company; Janssen Pharmaceuticals, Inc.; and Portola Pharmaceuticals, Inc.
Gregory Piazza, MD, MS, does not intend to discuss any non-FDA-approved or investigational use of any products/devices.
Eric I. Rosenberg, MD, MSPH, FACP
University of Florida College of Medicine
Eric I. Rosenberg, MD, MSPH, FACP, has no financial interests/relationships or affiliations in relation to this activity.
Tracy L. Greene, MSN, RN, FNP-C, Lead Nurse Planner, has no financial interests/relationships or affiliations in relation to this activity.
Janice Trainor-Tellier, MSN, RN, has no financial interests/relationships or affiliations in relation to this activity.
Teresa Haile, RPh, MBA, Lead Pharmacy Planner, has no financial interests/relationships or affiliations in relation to this activity.
Patricia A. Ensor, RPh, MBA, has no financial interests/relationships or affiliations in relation to this activity.
PVI, PeerView Institute for Medical Education
Carmine DeLuca has no financial interests/relationships or affiliations in relation to this activity.
PVI, PeerView Institute for Medical Education
Angela McIntosh has no financial interests/relationships or affiliations in relation to this activity.
The information provided at this CME/MOC/CNE/CPE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.
Providership, Credit, and Support
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Florida College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points and patient safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.
Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Participation information will be shared with ABIM through the ACCME's Program and Activity Reporting System (PARS). Blinded individual or aggregated participant data may be shared with the funder of the activity.
Medical Learning Institute, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Successful completion of this continuing nursing education activity will be awarded 0.5 contact hour(s)
The Medical Learning Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Completion of this knowledge-based activity provides for 0.5 contact hours (0.05 CEUs) of continuing pharmacy education credit. The Universal Activity Number for this activity is 0468-9999-18-019-H01-P.
This CME/MOC/CNE/CPE activity is jointly provided by University of Florida College of Medicine and PVI, PeerView Institute for Medical Education; this activity is also co-provided by Medical Learning Institute, Inc.
This activity is supported by an educational grant from the Bristol-Myers Squibb and Pfizer Alliance.
This CME/MOC/CNE/CPE activity has been developed in collaboration with the North American Thrombosis Forum.
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer's product labeling.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.
About This CME/MOC/CE/CPE Activity
PVI, PeerView Institute for Medical Education, the University of Florida College of Medicine, and Medical Learning Institute, Inc. are responsible for the selection of this activity's topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI, the University of Florida College of Medicine, and Medical Learning Institute, Inc.
Copyright © 2000-2019, PeerView
Postgraduate Healthcare Education, LLC (PHE) is the source of Power-Pak C.E.® continuing education for health care
professionals. Our accredited programs assist in meeting the requirements of licensure. PHE provides continuing
education for the broad spectrum of health care professionals. This site features a searchable database of accredited
Power-Pak C.E.® courses on important topics for today's health care professionals.
PHE customizes Power-Pak C.E.® online for each visitor by creating a personal participant profile. Registered participants
may update their contact information, take an exam, receive instant grading, view their exam history, and print certificates
for successfully completed programs at any time. Monthly notifications will be sent to participants notifying you of new
courses available on the site.